Stockreport

ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 [Yahoo! Finance]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF endpoint of the ACURATE IDE clinical trial, which evaluated the ACURATE neo2 ™ Aortic Valve System in the treatment of patients with severe, symptomatic aortic stenosis [Read more]